J Romaguera1, D Caballero-Varona2, G Tortolero-Luna3,4, E Marrero4,5, E Suárez5, C M Pérez5, C Muñoz4,5, J Palefsky6, A P Ortiz4,5. 1. Department of Obstetrics and Gynecology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico. josefina.romaguera@upr.edu. 2. School of Medicine, University of Puerto Rico, San Juan, Puerto Rico. 3. Department of Obstetrics and Gynecology, School of Medicine, University of Puerto Rico, San Juan, Puerto Rico. 4. University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico. 5. Department of Biostatistics and Epidemiology, Graduate School of Public Health, University of Puerto Rico, San Juan, Puerto Rico. 6. University of California, San Francisco, CA, USA.
Abstract
OBJECTIVES: The objective of this study was to investigate the factors associated with HPV awareness among women aged 16 to 64 years, among underserved minority Hispanic women living in Puerto Rico. METHODS: A population-based, cross-sectional sample of 566 women, ages 16 to 64 years, living in the San Juan metropolitan area were surveyed regarding sexual behavior, HPV knowledge, and HPV vaccine uptake. Data was analyzed using descriptive statistics and multivariate logistic regression. RESULTS: Overall, 64.8 % of the women in the sample had heard about the HPV vaccine. Among those in the recommended catch-up vaccination age range (16-26 years, n = 86), 4.7 % had received at least one dose of the HPV vaccine. Of those aware of the availability of the HPV vaccine, most had learned about it through the media, whereas, only 39.6 % had learned about it from a physician. Multivariate logistic regression analysis showed that HPV awareness (OR 8.6; 95 % CI 5.0-14.8) and having had an abnormal Pap smear (OR 2.0; 95 % CI 1.2-3.4) were associated with HPV vaccine awareness (p < 0.05). CONCLUSION: HPV vaccine awareness among Hispanic women in the San Juan metropolitan area of Puerto Rico continues to be low. Strong recommendations from physicians and participation in HPV vaccine educational efforts are essential if the rate of HPV vaccination is to increase in the targeted population. Compared to the USA, and to their US Hispanic counterparts, a health disparity with regard to HPV vaccine awareness and coverage is evident in Puerto Rico; targeted action to deal with this disparity is urgently needed.
OBJECTIVES: The objective of this study was to investigate the factors associated with HPV awareness among women aged 16 to 64 years, among underserved minority Hispanic women living in Puerto Rico. METHODS: A population-based, cross-sectional sample of 566 women, ages 16 to 64 years, living in the San Juan metropolitan area were surveyed regarding sexual behavior, HPV knowledge, and HPV vaccine uptake. Data was analyzed using descriptive statistics and multivariate logistic regression. RESULTS: Overall, 64.8 % of the women in the sample had heard about the HPV vaccine. Among those in the recommended catch-up vaccination age range (16-26 years, n = 86), 4.7 % had received at least one dose of the HPV vaccine. Of those aware of the availability of the HPV vaccine, most had learned about it through the media, whereas, only 39.6 % had learned about it from a physician. Multivariate logistic regression analysis showed that HPV awareness (OR 8.6; 95 % CI 5.0-14.8) and having had an abnormal Pap smear (OR 2.0; 95 % CI 1.2-3.4) were associated with HPV vaccine awareness (p < 0.05). CONCLUSION:HPV vaccine awareness among Hispanic women in the San Juan metropolitan area of Puerto Rico continues to be low. Strong recommendations from physicians and participation in HPV vaccine educational efforts are essential if the rate of HPV vaccination is to increase in the targeted population. Compared to the USA, and to their US Hispanic counterparts, a health disparity with regard to HPV vaccine awareness and coverage is evident in Puerto Rico; targeted action to deal with this disparity is urgently needed.
Entities:
Keywords:
HPV vaccine; Health awareness; Health disparities; Hispanics; Human papillomavirus; Puerto Ricans
Authors: Kelly D Blake; Allison J Ottenbacher; Lila J Finney Rutten; Meredith A Grady; Sarah C Kobrin; Robert M Jacobson; Bradford W Hesse Journal: Am J Prev Med Date: 2015-02-18 Impact factor: 5.043
Authors: Ana P Ortiz; Marievelisse Soto-Salgado; William A Calo; Guillermo Tortolero-Luna; Cynthia M Pérez; Carlos J Romero; Javier Pérez; Nayda Figueroa-Vallés; Erick Suárez Journal: Infect Agent Cancer Date: 2010-05-14 Impact factor: 2.965
Authors: A P Ortiz; V Tamayo; A Scorsone; M Soto-Salgado; I Febo; P Piovanetti; H L Venegas-Ríos; Y Yamamura; C Zorrilla Journal: Papillomavirus Res Date: 2017-06-19
Authors: Vivian Colón-López; Vilnery Rivera-Figueroa; Glizette O Arroyo-Morales; Diana T Medina-Laabes; Roxana Soto-Abreu; Manuel Rivera-Encarnación; Olga L Díaz-Miranda; Ana P Ortiz; Katelyn B Wells; Coralia Vázquez-Otero; Pamela C Hull Journal: BMC Public Health Date: 2021-07-01 Impact factor: 3.295
Authors: A P Ortiz; G Tortolero-Luna; J Romaguera; C M Pérez; D González; C Muñoz; L González; E Marrero; E Suárez; J M Palefsky; G Panicker; E R Unger Journal: Papillomavirus Res Date: 2018-03-16
Authors: Vivian Colón-López; Diana T Medina-Laabes; Roxana Soto Abreu; Olga L Díaz Miranda; Ana P Ortiz; María E Fernández; Pamela C Hull Journal: BMC Public Health Date: 2021-10-25 Impact factor: 3.295